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BACKGROUND: Framing of risk influences the percep-
tions of treatment benefit.
OBJECTIVE: To determine which risk framing format
corresponds best to comprehensive multi-faceted infor-
mation, and to compare framing bias in doctors and in
patients.
DESIGN: Randomized mail surveys.
PARTICIPANTS: One thousand four hundred and
thirty-one doctors (56% response rate) and 1121 re-
cently hospitalized patients (65% response rate).
INTERVENTION: Respondents were asked to interpret
the results of a hypothetical clinical trial comparing an
old and a new drug. They were randomly assigned to
the following framing formats: absolute survival (new
drug: 96% versus old drug: 94%), absolute mortality
(4% versus 6%), relative mortality reduction (reduction
by a third) or all three (fully informed condition). The
new drug was reported to cause more side-effects.
MAIN MEASURE: Rating of the new drug as more
effective than the old drug.
RESULTS: The proportions of doctors who rated the new
drug as more effective varied by risk presentation format
(abolute survival 51.8%, absolute mortality 68.3%, rela-
tive mortality reduction 93.8%, and fully informed condi-
tion 69.8%, p<0.001). In patients these proportions were
similar (abolute survival 51.7%, absolute mortality
66.8%, relative mortality reduction 89.3%, and fully
informed condition 71.2%, p<0.001). In both doctors (p
=0.72) and patients (p=0.23) the fully informed condition
was similar to the absolute risk format, but it differed
significantly from the other conditions (all p<0.01). None
of the differences between doctors and patients were
significant (all p > 0.1). In comparison to the fully informed
condition, the odds ratio of greater perceived effectiveness
was 0.45 for absolute survival (p<0.001), 0.89 for abso-
lute mortality (p=0.29), and 4.40 for relative mortality
reduction (p<0.001).
CONCLUSIONS: Framing bias affects doctors and
patients similarly. Describing clinical trial results as
absolute risks is the least biased format, for both doctors
and patients. Presenting several risk formats (on both
absolute and relative scales) should be encouraged.
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communication; patient information.
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INTRODUCTION
The mode of presentation of clinical trial results influences the
perception of treatment benefit1–10. Generally, relative risks (e.g.,
mortality reduction by half) accentuate the perception of benefit
compared to absolute risks (e.g., mortality was 5% versus 10%)
or numbers needed to treat (e.g., 20 patients need to be trated to
avoid one death). Similarly, negative framing (in terms of
mortality) leads to greater perception of benefit than positive
framing (in terms of survival).
The absolute risk format is often recommended because the
relative risk format causes misunderstandings11,12, but others
have argued against the provision of absolute risks13. Arguably,
no single format allows a well-informed opinion, which would
require careful consideration of all sides of the argument14. Only
a few recent tudies have included a “fully informed” condition in
their design, with variable results15–18. These studies enrolled
various volunteer samples, not patients or doctors, who are
directly concerned by treatment decisions. Thus available
evidence remains inconclusive.
Another unresolved question is whether patients and doctors
are affected similarly by framing formats. A meta-analysis has
suggested that both doctors and patients overrate treatment
benefits when presented with relative risks4, but no study has
probed doctors and patients using the same instruments. The
doctors’ greater familiarity with the assessment of medical
research findings, higher numeracy levels, and greater knowl-
edge of the relevant clinical context may make them less
susceptible to framing effects.
The objectives of this study were to determine which single
framing format approximates best the comprehensive informa-
tion format in terms of the perception of treatment benefit, and
to compare the impact of risk framing formats on doctors and
on patients.
METHODS
We conducted two randomized mail surveys that included a
hypothetical scenario among doctors and among patients
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recently discharged from hospital. The doctor survey pri-
marily explored doctors’ opinions about policy issue and
was approved by the Research Ethics Committee of the
University Hospitals of Geneva19,20; the patient survey,
primarily a patient satisfaction survey, was exempted from
full review21,22.
The doctor survey included all active clinicians in canton
Geneva, Switzerland, and was conducted between November
2007 and February 2008. Doctors were identified through
the registries of the Geneva Medical Association and Uni-
versity Hospitals of Geneva. Duplicate records, invalid
addresses and doctors who did not work with patients were
excluded. This left 2746 eligible doctors. The survey re-
sponse rate was of 56.3% (1546/2746). Participation was
not related to age, setting of practice and source data base,
but differed by sex (58.0% in men vs. 53.7% in women, p=0.027)
and specialty (from 52.6% in technical specialists to 62.2% in
primary care doctors, p=0.003).
The patient survey took place between November 2005 and
February 2006. It included all adult patients discharged to their
home during a one month period. No clinical data were
available, nor any information about the relevance of the study
scenario for the patient. We excluded patients who were
transferred to another facility, did not live in Switzerland, or
reported not speaking French or being incapable of filling a
questionnaire. The core of the questionnaire was the Picker
patient opinion survey. The response rate was 65.0% (1432/
2204).
Scenario
The scenario described a hypothetical clinical trial in which a
new treatment provided a survival benefit over the old
treatment, but caused more digestive side-effects (Box). Four
basic risk formats were used in both surveys: 1) survival
proportions, 2) mortality proportions, 3) relative mortality
reduction, and 4) all three presentations of risk. The latter
was considered to be the fully informed condition. The
respondent was asked how the new treatment compared with
the old treatment.
We tested two additional risk formats in doctors only: 5) the
number needed to treat, and 6) the relative survival extension.
These formats didnotworkwell with patients during pretests, and
we renounced their use in this sample. Furthermore, we called the
viral disease HIV infection in the doctor scenario, but not in the
patient scenario, to avoid singling out a specific patient group. The
studywas called a “multicenter clinical trial” in the doctor version,
but just “study” in the patient version. We mentioned statistical
significance in the doctor version because that question arose
during pretests, but not in the patient version.
Presentations of treatment benefits as absolute survival,
absolute mortality, relative mortality reduction, and number
needed to treat do not require elaboration. Computation of the
relative survival extension was based on the assumption of a
constant mortality rate (i.e., exponential model). Under this
assumption the expectation of survival time equals the inverse
of the mortality rate23; thus if the mortality rate with the new
drug is 2/3 of the mortality rate with the old drug, the expected
survival on the new drug will be 3/2 the expected survival on the
old drug, i.e., an increase of 50%. Of note, in the other versions of
the scenario, we reported risks rather than rates, but because
risks were low, the ratios of hazards and risks were practically
equivalent (an exact computation yields a survival extension of
51.2% for this case; we used the rounded figure of 50% for
simplicity).
Sample Size Determination
We sought to detect a difference in positive assessments of 60%
versus 75%. With a type 1 error at 5% and a desired power of
90%, 220 observations per group were necessary.
Analysis
We compared the distributions of the 5-level assessment across
versions of the scenario, and compared them using a chi-square
test for linear trend, separately in patients and in doctors. For
most analyses, we dichotomized the assessment as favorable
(“much better” or “somewhat better”) versus other, and used
chi-square tests to compare version of the scenario, and doctors
to patients within each version. Multivariate modeling was
conducted with logistic regression. The reference level was the
comprehensive information condition, and differences between
this and other risk frames were interpreted as framing bias. The
models were replicated using ordinal logistic regression with the
original 5-level assessment as dependent variable, but because
the results were virtually identical, we report binary logistic
regression results. To compare the effects of risk framing across
subgroups we used interaction terms; e.g., to compare men and
women, the model predictors included risk formats , sex, and the
sex*formats interaction.
RESULTS
Of the 1546 doctors who returned the questionnaire, 107 (6.9%)
left the scenario blank. Non-response was similar in men and
women (6.5% vs. 7.6%, p=0.38), but was higher in older doctors
(up to 35 years: 3.3%, 36–50 years: 6.4%, 51 and over: 9.2%, p-
value for trend=0.001), and in psychiatrists compared to other
specialties (12.6% vs. 5.6%, p<0.001). The doctor respondents
included a majority of men (Table 1), and their mean age was
47.0 years (standard deviation 11.6). Themajority were in private
practice. All clinical specialties were represented.
Non-completion of the scenario was higher among the 1432
patient respondents (311, 21.7%). Non-response was similar in
men and women (20.7% vs. 17.9%, p=0.20), but was higher in
older patients (up to35years: 10.2%, 36–50years: 16.0%, 51 and
over: 28.9%, p-value for trend<0.001), patients who had less
than high school education (23.1%) versus the more educated
(12.0%, p<0.001), and in patients who reported poor to good
health (21.4%) compared to those in excellent or very good health
(11.4%, p<0.001). The majority of patient participants were
women (Table 1), and their mean age was 51.0 years (standard
deviation 18.7). Slightlymore than half had only basic education;
about a third reported very good or excellent health.
Scenario Assessments
Most doctors considered the new treatment to be better than the
old treatment, but the proportions of positive assessments varied
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considerably across formats (Table 2). E.g., the proportion that
rated the new treatment “clearly better” exceeded 60% for relative
formats (relative mortality reduction, relative survival extension),
but less than 10% for absolute survival. The differences between
the six formats were statistically significant (p<0.001). In
comparison to the fully informed format, the distribution of
responses was similar for the absolute risk format (p=0.42), but
differed significantly for all others (p=0.009 for the NNT format,
and <0.001 for the others).
The pattern of responses was similar for patients, but the
contrasts appeared somewhatmore attenuated, andmorenegative
opinionswere expressed (Table 2). The differences between formats
were statistically significant overall (p<0.001), and in comparison
to the fully informed condition, the difference was non-significant
for absolutemortality (p=0.80), but significant for absolute survival
and for relative mortality reduction (both p<0.001).
Collapsing the two positive categories (clearly or somewhat
better) yielded results that were almost indistinguishable for
doctors and patients (Table 3). About 50% of respondents
considered the new treatment better when absolute survival was
shown, about 70% did when comprehensive information or
absolute mortality was shown, and about 90% did when relative
mortality or relative survival extension were shown. None of the
comparisons of doctors with patients was significant.
The logistic regression model confirmed these results
(Table 4). Compared to the fully informed condition, the
odds of a favorable assessment of the new drug were
fourfold for relative mortality reduction and relative survival
extension, less increased for the number needed to treat,
similar for absolute mortality, and reduced more than
twofold for absolute survival. The difference between doctors
and patients was small and non-significant.
Subgroup Analyses
The only difference that we anticipated (attenuated framing effects
in doctors compared with patients) was not borne out by the data
(p value of interaction test =0.40). Among doctors, the impact of
risk framing was similar across subgroups: interaction terms
between format and sex (p=0.78), age group (p=0.50), site of
practice (p=0.84), and specialty (p=0.80) were all non-significant.
Similarly, among patients, no significant interactions were found
between risk framing and sex (p=0.82), age groups (p=0.35),
education level (p=0.85), country of birth (p=0.17), health status
(p=0.71), and hospital department (p=0.91).
DISCUSSION
Risk Formats
Our study confirms that the risk information format influ-
ences perceptions of treatment benefit: absolute survival led
to the perception of weakest benefit, and relative mortality
reduction led to the perception of greatest benefit. To this we
add two novel findings: comprehensive information that
combined absolute mortality, absolute survival, and relative
mortality reduction produced a similar perception of bene-
fits to the presentation of absolute mortality, and the
susceptibility to framing bias was similar in doctors and
patients.
If respondent perceptions following comprehensive infor-
mation are used as a yardstick, absolute risks constitute
the least biased risk format. In contrast, presentation of
relative risk reductions in isolation caused an optimistic
bias, with a more than fourfold increase in the odds of a
positive assessment of the new treatment. Presentation of
absolute survival proportions caused a pessimistic bias,
with a more than twofold decrease in the odds of a
favorable assessment. The differences we observed between
these risk formats are consistent with the results of a
recent meta-analysis on the subject4. The novel aspect
contributed by this study is the inclusion of a fully
informed condition, which aimed to capture the “true”
values and preferences of the respondents. Indeed, on face
value, all perceptions of treatment benefit are equally valid.
As long as the data on which these perceptions are based
are correct (and a relative risk is as technically correct as
two survival proportions), it cannot be said that one
perception is right and the other wrong. Arguably, the
“right” answer is one that the respondent arrived at after
careful consideration of all arguments, preferably after
sufficient reflection time, and after clarification of any
questions that may have occurred. This is the ideal that
we attempted to approach, however imperfectly, through
the “comprehensive information” condition.
Table 1. Characteristics of Doctors and Patients Who Completed
the Risk Assessment Scenario (Totals May Not Add up to Total Due
to Missing Values)
Doctors
(N=1439)
Patients
(N=1121)
Sex:
Men 894 (62.1) 449 (40.5%)
Women 544 (37.8) 661 (59.5%)
Age:
≤35 years 294 (20.4) 298 (26.6%)
36-50 years 573 (39.8) 273 (24.4%)
>50 years 572 (39.7) 572 (49.0%)
Type of practice: NA
Hospital, in training 495 (34.4)
Hospital, senior 143 (9.9)
Private practice 801 (55.7)
Specialty: NA
Technical specialties* 423 (29.5)
Primary care 422 (29.5)
Psychiatry 250 (17.5)
Internal medicine specialties 220 (15.4)
Pediatrics 117 (8.2)
Education: NA
Elementary or vocational 579 (53.0)
High school, university or technical 514 (47.0)
Health status: NA
Poor, fair or good 721 (65.8)
Very good or excellent 374 (34.2)
Discharged from department of: NA
Surgery 378 (33.8)
Gynecology-obstetrics 276 (24.7)
Medicine 212 (18.9)
Neurosciences 171 (15.3)
Psychiatry 56 (5.0)
Geriatrics 26 (2.3)
* Surgery, anesthesiology, gynecology-obstetrics, ear, nose and throat,
ophthalmology, radiology
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A few previous studies have compared isolated risk frames
to a fully informed condition. Stovring et al. have followed an
initial presentation of treatment benefit by a comprehensive
description; initial presentation in the absolute risk reduc-
tion of a heart attack led to fewer changes in the decision to
take the drug (6%) than if the initial presentation was a
relative risk reduction (9%), but this difference was not
statistically significant15. Carling et al. reported that framing
the risks of cardiovascular events initially as a rate (events
per year) resulted in fewer changes in decisions (19.1%) than
describing a cumulative risk over 10 years (28.2%) or disease-
free survival over 10 years (23.8%)16. Armstrong et al. have
reported that showing survival and mortality curves together
led to similar decisions regarding a preventive colectomy as
showing survival curves alone, but not mortality curves
alone17. Peters et al. have observed that a positive frame
(absence of an adverse drug reaction) led to lower perceptions
of risk than a negative frame (risk of adverse event), with the
combined frame presentation falling in-between18. These
studies have shown weak and somewhat inconsistent con-
trasts, while we have observed a strong and statistically
significant differences. This raises the issue of contextual
factors which may influence study results, such the type of
scenario, the exact question asked, or the type of study
population. All four aforementioned studies were conducted
among various volunteer samples from the general popula-
tion, while we surveyed patients and doctors.
Doctors Versus Patients
The second novel finding of this study is that doctors are just
as prone to framing bias as patients. The results of doctors and
patients were remarkably similar when the perceptions were
dichotomized as positive versus neutral or negative. This was
unexpected—we thought that doctors would be more sophis-
ticated than patients in interpreting the scenario, less likely to
be convinced by a relative mortality reduction with no absolute
risk to anchor the comparison, and more apt to deduce the
proportion of patients who died when the proportion who
survived was given. This illustrates the difficulty that many
doctors have in applying quantitative analysis skills in their
practice. Previous studies have shown that doctors’ under-
standing of various terms used in medical literature, such as
relative risk, absolute risk, or the number needed to treat,
differ considerably from an objective, criterion based assess-
ment24. Similarly, most doctors misunderstand numerical
data regarding test accuracy, regardless of whether they are
presented as sensitivity and specificity or likelihood ratios25,
and fail to use relevant numerical information, such as disease
prevalence, when they interpret the results of diagnostic
tests20,26. Were doctors less prone to framing bias than
patients, it would be possible to simply warn doctors of the
Table 2. Distributions of Perceptions of Benefit of a New Treatment, by Rsk Presentation Format, Among 1439 Doctors and 1121 Patients
Recently Discharged from Hospital, in Geneva, Switzerland
Doctors
Clearly better Somewhat better About the same Somewhat worse Clearly worse
Comprehensive information*, N=242 27.7% 42.1% 29.3% 0.8% 0.0%
Absolute survival (96% v. 94%), N=245 7.8% 44.1% 41.2% 5.3% 1.6%
Absolute mortality (4% v. 6%), N=243 27.2% 41.2% 28.8% 2.9% 0.0%
Relative mortality reduction (by one third), N=224 67.0% 26.8% 5.8% 0.4% 0.0%
Number needed to treat (50 to avoid 1 death), N=239 34.3% 47.3% 16.3% 1.3% 0.8%
Relative survival extension (by half), N=245 60.4% 31.4% 7.3% 0.4% 0.4%
Patients
Clearly better Somewhat better About the same Somewhat worse Clearly worse
Comprehensive information*, N=264 23.5% 47.7% 24.8% 2.3% 1.9%
Absolute survival (96% v. 94%), N=286 14.7% 37.1% 36.4% 8.7% 3.1%
Absolute mortality (4% v. 6%), N=298 20.8% 46.0% 27.5% 3.0% 2.7%
Relative mortality reduction (by one third), N=271 48.0% 41.3% 7.7% 1.8% 1.1%
* Absolute survival, absolute mortality, and relative mortality reduction
Table 3. Proportions of Doctors and Patients with a Positive
Perception of the Benefits of a New Treatment (Clearly Better or
Somewhat Better)
Risk presentation
format
Doctors Patients P value comparing
doctors and patients
1) Comprehensive
information*
69.8% 71.2% 0.73
2) Absolute survival 51.8% 51.7% 0.98
3) Absolute mortality 68.3% 66.8% 0.71
4) Relative mortality
reduction
93.8% 89.3% 0.11
P value comparing
formats 1-4
<0.001 <0.001
5) Number needed to treat 81.6% NA NA
6) Relative survival
extension
91.8% NA NA
P value comparing
formats 1-6
<0.001 NA
* Absolute survival, absolute mortality, and relative mortality reduction
Table 4. Odds Ratios for a Positive Perception of the Benefits of a
New Treatment
Odds ratio (95% CI) P value
Risk presentation format
(versus comprehensive information)
Absolute survival 0.45 (0.35 – 0.58) <0.001
Absolute mortality 0.87 (0.67 – 1.13) 0.29
Relative mortality reduction 4.40 (3.05 – 6.34) <0.001
Number needed to treat* 1.79 (1.21 – 2.66) 0.004
Relative survival extension* 4.55 (2.74 – 7.55) <0.001
Doctor (versus patient) 1.06 (0.87 – 1.29) 0.55
* only tested among doctors
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patients’ limited capacity to interpret numerical risk data, and
suggest various communication aids to improve patient un-
derstanding. As it is, doctors themselves may not be aware of
the problem. More systematic reporting of absolute risks may
be advisable in medical research reports and other original
sources of medical information used by doctors. In this our
findings support the recent addition to the CONSORT state-
ment that “For binary outcomes, presentation of both relative
and absolute effect sizes is recommended”27.
The comparability of framing effects in doctors and patients
and the lack of anymeaningful subgroup difference both suggest
that framing biases are widespread, if not universal. However, we
were not able to examine the personal context of the respondent,
notably the direct relevance of the treatment under consider-
ation. It is possible that study results are examined more
carefully by potential users of a treatment, and that framing
biases may be less prominent in such a situation.
Strengths and Limitations
We have used a robust design—randomized scenario-based
trial—and applied it to large samples of patients and doctors,
who are directly concerned by risk framing and treatment
decisions. All scenarios described identical study results, so
that only framing of information could explain the differences
between responses.
Themain limitation of the study is that only one situation was
depicted. We do not know what would have happened had we
described risks of an event other than death, if the risks had been
20% and 30%, instead of 4% and 6%, if the relative mortality
reduction had been of one half or one tenth instead of one third,
etc. Nevertheless the intent of this study was not to establish
some universally valid constants (we do not believe that they
exist), but rather to identify the format that best approaches the
fully informed condition.We believe that the general answers that
we obtained—absolute risks are the least biased, doctors are as
sensitive to framing bias as patients—have a more general
validity than any specific percentages obtained in this study.
Another limitation is that we do not know whether our
“comprehensive information” condition achieved its purpose
for all respondents. In real life, an optimal information process
would allow for additional questions, further explanations, and
sufficient time to reflect on the information, all things that could
not be offered via a scenario. Therefore replication of our
findings in clinical studies would be useful. A clinical study
would also confirm whether our results hold for actual deci-
sions, which is always a concern for simulation studies. In this
case, we would argue that the real-life and simulated situations
are similar, as both entail reading numerical results of a study
and forming an opinion about the new drug. Finally, a clinical
study would allow an exploration of the link between percep-
tions of benefit and actual decisions to prescribe, recommend,
or agree to a new treatment.
As for most surveys, selection bias is a concern. Skipping
the scenario was common among patients, particularly
among older and less educated patients. This suggests that
despite pretests, understanding and answering the scenario
was not trivial. Whether this reflects a general difficulty
inherent in interpreting risk data, or specific features of our
scenario, cannot be determined. Finally, participation was
average in both surveys (56% and 65%), which can also
cause selection bias.
CONCLUSIONS
Presentation of study results in terms of absolute mortality risks
leads to least biasedperceptions of the benefit of a new treatment,
whena combination of three risk formats is used as the reference.
In comparison, relative presentations of benefit cause an opti-
mistic bias, and survival proportions induce a pessimistic bias.
Doctors are just as prone to these biases as patients.
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